CIK 0001267565 · Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-15 | Heffernan Michael Thomas Director | Sale | −6,517 | $13.13 | $86K | 182,069 |
| 2019-04-25 | Heffernan Michael Thomas Director | Grant or award | +4,707 | 207,069 | ||
| 2019-04-25 | Heffernan Michael Thomas Director | Grant or award · Stock Option (Right to Purchase) | +9,414 | 9,414 | ||
| 2019-04-25 | Fallon John A. Director | Grant or award | +4,707 | 9,335 | ||
| 2019-04-25 | Fallon John A. Director | Grant or award · Stock Option (Right to Purchase) | +9,414 | 9,414 | ||
| 2019-04-25 | Schroeder Theodore R Director | Grant or award | +4,707 | 6,960 | ||
| 2019-04-25 | Schroeder Theodore R Director | Grant or award · Stock Option (Right to Purchase) | +9,414 | 9,414 | ||
| 2019-04-25 | Hirsch David Director | Grant or award | +4,707 | 44,370 | ||
| 2019-04-25 | Hirsch David Director | Grant or award · Stock Option (Right to Purchase) | +9,414 | 9,414 | ||
| 2019-04-25 | Freund John Gordon Director | Grant or award | +4,707 | 6,960 | ||
| 2019-04-25 | Freund John Gordon Director | Grant or award · Stock Option (Right to Purchase) | +9,414 | 9,414 | ||
| 2019-04-25 | SANTINI GINO Director | Grant or award | +4,707 | 30,148 | ||
| 2019-04-25 | SANTINI GINO Director | Grant or award · Stock Option (Right to Purchase) | +9,414 | 9,414 | ||
| 2019-04-25 | BOHLIN GAREN G Director | Grant or award | +4,707 | 6,960 | ||
| 2019-04-25 | BOHLIN GAREN G Director | Grant or award · Stock Option (Right to Purchase) | +9,414 | 9,414 | ||
| 2019-04-25 | Melincoff Gwen A Director | Grant or award | +4,707 | 6,960 | ||
| 2019-04-25 | Melincoff Gwen A Director | Grant or award · Stock Option (Right to Purchase) | +9,414 | 9,414 | ||
| 2019-04-15 | Heffernan Michael Thomas Director | Sale | −20,192 | $14.91 | $301K | 207,170 |
| 2019-04-15 | Heffernan Michael Thomas Director | Sale | −4,808 | $15.87 | $76K | 202,362 |
| 2019-04-01 | Malamut Richard EVP and Chief Medical Officer | Grant or award | +42,500 | 42,500 |
Page 27 of 32 · 635 trades